Tissue Regenix Group Plc (TRX) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.11x

Tissue Regenix Group Plc (TRX) has a Cash Flow Reinvestment Rate of 0.11x as of December 2023, reinvesting GBX153.75K (capex GBX153.75K ) from operating cash flow of GBX1.36 Million. Check Tissue Regenix Group Plc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.11x

(Capex + Investments) / Operating CF

Total Reinvested

GBX153.75K

Capex + Investments

Operating Cash Flow

GBX1.36 Million

GBX

Capital Expenditures

GBX153.75K

GBX

Tissue Regenix Group Plc Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Tissue Regenix Group Plc across 1 annual periods. Explore debt repayment capacity of Tissue Regenix Group Plc to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Tissue Regenix Group Plc (2023–2023)

Year-by-year capital reinvestment analysis for Tissue Regenix Group Plc. For live market cap and broader valuation context, see market cap of Tissue Regenix Group Plc.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2023	1.63x	GBX1.70 Million	GBX1.04 Million	GBX863.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow